Celecoxib-induced gastrointestinal, liver and brain lesions in rats, counteraction by [PMID: 28839430] Laboratory literature summary: Celecoxib-induced gastrointestinal, liver and brain lesions in rats, counteraction by BPC 157 or L-arginine, aggravation by L-NAME
European journal of pharmacology, 570(1-3), 212221
Patients should: Follow the dose escalation schedule to minimise side effects Attend regular follow-up appointments to monitor progress and safety Engage with dietetic support to ensure adequate nutrition whilst reducing calorie intake Combine medication with increased physical activity (aim for 150 minutes moderate-intensity exercise weekly, plus muscle-strengthening activities on at least 2 days per week, as per UK Chief Medical Officers' guidelines) Structured lifestyle programmes : NICE recommends multicomponent interventions including dietary modification, physical activity, and behavioural strategies
Popular examples include CJC-1295 + Ipamorelin , Sermorelin , and certain IGF-related peptides